Supernus Pharmaceuticals Inc SUPN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 09/30/22 EDT
33.85UNCH (UNCH)
Volume
54,974
Close
33.85quote price arrow up+0.57 (+1.71%)
Volume
668,947
52 week range
24.95 - 36.08
Loading...
  • Open33.38
  • Day High34.33
  • Day Low33.31
  • Prev Close33.28
  • 52 Week High36.08
  • 52 Week High Date08/22/22
  • 52 Week Low24.95
  • 52 Week Low Date05/11/22

Key Stats

  • Market Cap1.811B
  • Shares Out53.50M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change16.08

KEY STATS

  • Open33.38
  • Day High34.33
  • Day Low33.31
  • Prev Close33.28
  • 52 Week High36.08
  • 52 Week High Date08/22/22
  • 52 Week Low24.95
  • 52 Week Low Date05/11/22
  • Market Cap1.811B
  • Shares Out53.50M
  • 10 Day Average Volume0.50M
  • Dividend-
  • Dividend Yield-
  • Beta0.99
  • YTD % Change16.08

RATIOS/PROFITABILITY

  • EPS (TTM)0.99
  • P/E (TTM)34.30
  • Fwd P/E (NTM)23.39
  • EBITDA (TTM)136.634M
  • ROE (TTM)7.07%
  • Revenue (TTM)630.07M
  • Gross Margin (TTM)88.34%
  • Net Margin (TTM)9.12%
  • Debt To Equity (MRQ)47.65%

EVENTS

  • Earnings Date11/01/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Supernus Pharmaceuticals Inc

 

Content From Our Affiliates

Profile

MORE
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. The Company's diverse neuroscience portfolio includes treatments for epilepsy, migraine, attention deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and...
Charles Newhall III
Independent Chairman of the Board
Jack Khattar
President, Chief Executive Officer, Secretary, Director
Timothy Dec CPA
Chief Financial Officer, Senior Vice President
Address
9715 Key West Avenue
Rockville, MD
20850
United States

Top Peers

SYMBOLLASTCHG%CHG
PCRX
Pacira Biosciences Inc
53.19-1.05-1.94%
IRWD
Ironwood Pharmaceuticals Inc
10.36-0.01-0.10%
AMPH
Amphastar Pharmaceuticals Inc
28.10-0.89-3.07%
TVTX
Travere Therapeutics Inc
24.64UNCHUNCH
HRMY
Harmony Biosciences Holdings Inc
44.29+0.65+1.49%